Spatial patterning of fibroblast TGFß signaling underlies treatment resistance in rheumatoid arthritisFlinders Univ S Australia, Australia; Flinders Med Ctr, Australia.
Harvard Med Sch, MA 02115 USA.
Harvard Med Sch, MA 02115 USA.
Queen Mary Univ London, England; Natl Inst Hlth & Care Res NIHR, England.
Harvard Med Sch, MA 02115 USA.
Flinders Univ S Australia, Australia; Flinders Med Ctr, Australia.
Flinders Univ S Australia, Australia; Flinders Med Ctr, Australia.
Harvard Med Sch, MA USA.
Harvard Med Sch, MA 02115 USA.
Harvard Med Sch, MA 02115 USA.
Brigham & Womens Hosp, MA USA.
Brigham & Womens Hosp, MA USA.
Univ Colorado, CO USA.
Hosp Special Surg, NY USA.
Hosp Special Surg, NY USA; Weill Cornell Med, NY USA; Univ Queensland, Australia.
Weill Cornell Med, NY USA; Broad Inst MIT & Harvard, MA USA.
Univ Colorado, CO USA.
Univ Colorado Anschutz, CO USA.
Univ Colorado, CO USA.
Univ Colorado, CO USA.
Univ Colorado, CO USA.
Univ Colorado, CO USA; Childrens Hosp Colorado, CO USA.
Univ Colorado, CO USA.
Univ Colorado, CO USA.
Univ Colorado, CO USA.
Univ Colorado, CO USA.
Univ Colorado, CO USA.
Univ Colorado, CO USA.
Univ Colorado, CO USA.
Univ Colorado, CO USA.
Univ Colorado, CO USA.
Univ Birmingham, England; Univ Birmingham, England; Univ Birmingham, England.
Queen Mary Univ London, England; Natl Inst Hlth & Care Res NIHR, England.
Univ Colorado, CO USA.
Queen Mary Univ London, England; Natl Inst Hlth & Care Res NIHR, England.
Harvard Med Sch, MA 02115 USA.
Harvard Med Sch, MA 02115 USA.
Harvard Med Sch, MA 02115 USA; Harvard Med Sch, MA USA; Univ Birmingham, England; Broad Inst MIT & Harvard, MA USA; Harvard Med Sch, MA USA.
Flinders Univ S Australia, Australia; Flinders Med Ctr, Australia; Univ Birmingham, England; Weill Cornell Med, NY USA.
Harvard Med Sch, MA 02115 USA; Univ Birmingham, England; Weill Cornell Med, NY USA.
Show others and affiliations
2026 (English)In: Nature Immunology, ISSN 1529-2908, E-ISSN 1529-2916, Vol. 27, p. 556-571Article in journal (Refereed) Published
Abstract [en]
Treatment-refractory rheumatoid arthritis (RA) is a major unmet need, and the underlying mechanisms are poorly understood. To identify molecular determinants of refractory RA, we performed spatial transcriptomic profiling on synovial tissue biopsy samples taken 6 months before and after treatment. In the baseline biopsy samples of non-remitting patients, we identified increased fibrogenic signaling within vascular tissue niches, marked by high fibroblast COMP expression. We uncovered a role of endothelial-derived Notch signaling as an upstream regulator of fibroblast transforming growth factor beta (TGF beta) signaling via its opposing ability to induce TGF beta isoform expression while suppressing TGF beta receptors, generating a proximal-to-distal gradient of TGF beta sensitivity that can be altered with disruption of steady-state Notch signaling. In posttreatment biopsy samples, we observed significant immune depletion with expansion of fibrogenic niches, a process that can be reversed by inhibition of Notch and TGF beta signaling in RA patient-derived organoids. Collectively, our data implicate targeting of TGF beta signaling to prevent exuberant synovial tissue fibrosis as a potential therapeutic strategy for refractory RA.
Place, publisher, year, edition, pages
NATURE PORTFOLIO , 2026. Vol. 27, p. 556-571
National Category
Cell and Molecular Biology
Identifiers
URN: urn:nbn:se:liu:diva-220751DOI: 10.1038/s41590-025-02386-2ISI: 001661779900001PubMedID: 41540265Scopus ID: 2-s2.0-105027758350OAI: oai:DiVA.org:liu-220751DiVA, id: diva2:2032788
Note
Funding Agencies|U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K08AR077037, T32AR007530-36]; Burroughs Wellcome Fund Career Awards for Medical Scientists
2026-01-272026-01-272026-03-26